157 related articles for article (PubMed ID: 16436346)
1. Lipoprotein (a) and nitrites in Behcet's disease: relationship with disease activity and vascular complications.
Esmat S; El Sherif H; Anwar S; Fahmy I; Elmenyawi M; Shaker O
Eur J Dermatol; 2006; 16(1):67-71. PubMed ID: 16436346
[TBL] [Abstract][Full Text] [Related]
2. Serum lipoprotein (a) levels and Behçet's disease: is there an association?
Balik O; Gur G; Lenk N; Artuz F; Alli N
Int J Dermatol; 2007 Aug; 46(8):827-9. PubMed ID: 17651165
[TBL] [Abstract][Full Text] [Related]
3. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
[TBL] [Abstract][Full Text] [Related]
4. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine: an activity marker in Behçet's disease?
Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
[TBL] [Abstract][Full Text] [Related]
6. Increased serum ferritin levels in active Behçet's disease.
Odabas AR; Karakuzu A; Cetinkaya R; Selcuk Y; Keles S; Bilen H
Int J Clin Pract; 2002 May; 56(4):310-1. PubMed ID: 12074217
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein(a) concentrations in patients with type 2 diabetes mellitus without cardiovascular disease: relationship to metabolic parameters and diabetic complications.
Tarkun I; Cetinarslan B; Cantürk Z
Nutr Metab Cardiovasc Dis; 2002 Jun; 12(3):127-31. PubMed ID: 12325469
[TBL] [Abstract][Full Text] [Related]
8. Serum galectin-3 levels in patients with Behçet's disease: association with disease activity over a long-term follow-up.
Özden MG; Caycı YT; Tekin H; Çoban AY; Aydın F; Sentürk N; Bek Y; Cantürk T; Turanlı AY
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1168-73. PubMed ID: 21214630
[TBL] [Abstract][Full Text] [Related]
9. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
10. Serum mannose-binding lectin levels are decreased in behcet's disease and associated with disease severity.
Inanc N; Mumcu G; Birtas E; Elbir Y; Yavuz S; Ergun T; Fresko I; Direskeneli H
J Rheumatol; 2005 Feb; 32(2):287-91. PubMed ID: 15693089
[TBL] [Abstract][Full Text] [Related]
11. Decreased nitric oxide and increased platelet aggregation levels in patients with Behçet's disease.
Yapişlar H; Aydogan S; Borlu M; Ascioglu O
Thromb Res; 2007; 119(4):461-5. PubMed ID: 16806408
[No Abstract] [Full Text] [Related]
12. Serum and erythrocyte adenosine deaminase activities in patients with Behçet's disease.
Canpolat F; Unver M; Eskioğlu F; Kösebalaban S; Durmazlar SP
Int J Dermatol; 2006 Sep; 45(9):1053-6. PubMed ID: 16961545
[TBL] [Abstract][Full Text] [Related]
13. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
[TBL] [Abstract][Full Text] [Related]
14. Tetanus antitoxin seroprevalence in patients with Behçet's disease.
Ayaslioglu E; Erkek E; Kiliç D; Kaygusuz S; Karaca F; Düzgün N
Scand J Infect Dis; 2003; 35(5):299-301. PubMed ID: 12875513
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of allantoin levels as a new marker of oxidative stress in Behçet's disease.
Yardim-Akaydin S; Sepici A; Ozkan Y; Simşek B; Sepici V
Scand J Rheumatol; 2006; 35(1):61-4. PubMed ID: 16467045
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor gene polymorphisms and serum levels in Behçet's disease.
Kamoun M; Houman MH; Hamzaoui A; Hamzaoui K
Tissue Antigens; 2008 Dec; 72(6):581-7. PubMed ID: 19054372
[TBL] [Abstract][Full Text] [Related]
17. The levels of serum neopterin in Behçet's disease--objective marker of disease activity.
Köse O; Arca E; Akgül O; Erbil K
J Dermatol Sci; 2006 May; 42(2):128-30. PubMed ID: 16600572
[No Abstract] [Full Text] [Related]
18. Elevated oxidative stress markers and its relationship with endothelial dysfunction in Behçet disease.
Acikgoz N; Ermiş N; Yağmur J; Cansel M; Karincaoğlu Y; Ataş H; Cuglan B; Barutcu I; Pekdemir H; Özdemir R
Angiology; 2011 May; 62(4):296-300. PubMed ID: 20947865
[TBL] [Abstract][Full Text] [Related]
19. Reduced erythrocyte deformability in active and untreated Behçet's disease patients.
Tatlican S; Duran FS; Eren C; Eskioglu F; Dikmenoglu N; Oktay B; Durmazlar SP; Canpolat F
Int J Dermatol; 2010 Feb; 49(2):167-71. PubMed ID: 20465640
[TBL] [Abstract][Full Text] [Related]
20. Serum interleukin-8 as a serologic marker of activity in Behçet's disease.
Gür-Toy G; Lenk N; Yalcin B; Aksaray S; Alli N
Int J Dermatol; 2005 Aug; 44(8):657-60. PubMed ID: 16101867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
